Target macular edema

OFFHEALTH was born with the ambition to be a leading player in the world of ophthalmology through research and innovation.

With this in mind, one of the first goals was to create a product that would respond, in a simple but practical way, to the needs of patients with retinal disorders characterized by retinal edema or undergoing treatment with intra-vitreal drugs.

OFFHEALTH has addressed this challenge, focusing on the three key clinical aspects that are associated with this condition:

• The edema
• Inflammation
• Neo-angiogenesis